|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Selling, general and administrative expense | |||||
| Research and development expense | |||||
| Impairment of purchased intangibles and related items, net | |||||
| Income from operations | |||||
| Interest expense | |||||
| Foreign currency exchange gains, net | |||||
| (Gains) losses from change in fair market value of equity securities and loan receivable | |||||
| Other income, net | |||||
| Net income (loss) before income taxes | |||||
| (Provision for) benefit from income taxes | |||||
| Net income (loss) | |||||
| Basic earnings (loss) per share: | |||||
| Net income (loss) per basic share (in dollars per share) | |||||
| Weighted average common shares - basic (in shares) | |||||
| Diluted earnings (loss) per share: | |||||
| Net income (loss) per diluted share (in dollars per share) | |||||
| Weighted average common shares - diluted (in shares) |
Loading...
